DBDNA
LIVE

Serial Number

99041704

Owner

Touchlight IP Limited

Attorney

Rebecca Liebowitz

Filing Date

Feb 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DBDNA Trademark

Serial Number: 99041704 • Registration: 8092190

DBDNA is a trademark filed by Touchlight IP Limited on February 14, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Touchlight IP Limited (15 trademarks)

Morelands And Riverdale Buildings

Entity Type: 99

Trademark Details

Filing Date

February 14, 2025

Registration Date

January 6, 2026

Published for Opposition

November 18, 2025

Goods & Services

Chemicals, enzymes, nucleic acid constructs and viral vectors for scientific and research use; nucleic acid constructs and viral vectors for use in the manufacture of nucleic acids; nucleic acid constructs and viral vectors for manufacturing viruses; nucleic acid constructs and viral vectors for use in scientific research, agribiotechnology, and nanotechnology; all of the aforementioned goods not for medical or veterinary use

Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and viral vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for medical use; nucleic acid constructs and viral vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and viral vectors for gene therapy; nucleic acid constructs and viral vectors for use in cell therapy; nucleic acid constructs and viral vectors for use in genome editing; nucleic acid constructs and viral vectors for use in therapy

Scientific and technological services, namely, research and design in the fields of chemicals, enzymes, nucleic acid constructs, and viral vectors; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; research, analysis, design, and development relating to therapies, prophylactics, and counteragents based on nucleic acid constructs; research and development in the fields of gene therapy, diagnostic preparation, agribiotechnology, and nanotechnology; consultancy relating to the aforesaid services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 29, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2025 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 25, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2025 REAP
APPLICATION FILING RECEIPT MAILED
Feb 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2025 NWOS
NEW APPLICATION ENTERED
Feb 14, 2025 NWAP